Impact of Telehealth Warfarin Education on Patient Retention

Brief Summary

Detailed Description

2. This study is conducted in outpatient ambulatory care clinics at the Baylor Family Medicine Worth Street clinic and the Irving Interfaith clinic. The average census for warfarin patients Friday clinic is 10. The anticoagulation clinic consists of an interdisciplinary team including physicians, medical assistants, nurse practitioners, and pharmacists. Patients initially visit with the provider and subsequent follow up INR checks are performed by the pharmacists or medical assistants. Currently, pharmacists manage the anticoagulation clinic on Fridays and medical assistants manage the clinic on Monday through Thursday. All providers provide patient education through written brochures. 3. Study Design a. This study is a prospective, single-centered, randomized controlled quality improvement pilot study. 4. Warfarin Education Procedures 1. Each Friday morning, the pharmacist will identify the patients with appointments for INR checks. 2. As each patient checks in for their appointment, the pharmacist will ask the patient for consent to be a part of the study 3. If the patient says yes, the pharmacist will have the patient complete a warfarin questionnaire and health literacy test to see the patient's baseline knowledge on their warfarin therapy 4. Intervention patients (iPAD® video) 1. The patient will then watch a warfarin education video on the iPAD® 2. After the video the patient will receive point of care INR check and have their warfarin dose adjusted 3. Patient will then complete the same warfarin questionnaire 4. After completion, answers to the questionnaire will be presented to the patient. A written brochure will be given. 5. A satisfaction survey will be given 6. 30-60 days days later the pharmacist will follow up with the patient to repeat the warfarin questionnaire 5. Description of iPAD video a. Setting: a pharmacy b. Description: A pharmacist will provide education about warfarin using not only verbal instructions but also provide illustrations of directions. Please refer to Appendix for dialogue. 6. Control group a. Patients' INR will be taken and warfarin education will be given verbally similar to Monday-Thursday clinic. A written brochure will be given.

Primary Outcomes

Secondary Outcomes

• Self Reported Adherence to Warfarin therapy during duration of study(Between initial and follow up visit ( max 30 days))
• Satisfaction Survey(Max 30 days)
• Adverse Events(Between initial and follow up visit ( max 30 days))
• Time of Warfarin in Therapeutic Range for Duration of Study(Between initial and follow up visit ( max 30 days))